Stay updated with breaking news from Sciences Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lincoln National Corp bought a new position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) in the fourth quarter, Holdings Channel reports. The institutional investor bought 5,359 shares of the medical research company’s stock, valued at approximately $265,000. A number of other hedge funds also recently bought and sold shares of the company. Vanguard Group […]
Swiss National Bank reduced its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 5.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 719,180 shares of the medical research company’s stock after selling 43,237 shares during the period. Swiss National Bank owned […]
Biondo Investment Advisors LLC trimmed its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 10.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 102,764 shares of the medical research company’s stock after selling 11,686 shares during […]
TriaGen Wealth Management LLC bought a new position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 6,109 shares of the medical research company’s stock, valued at approximately $302,000. A number of other large investors have […]
Pictet & Cie Europe SA grew its position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 4.9% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 143,368 shares of the medical research company’s stock after purchasing an additional 6,655 shares during the period. Pictet & Cie Europe SA’s holdings in Exact Sciences were […]